Skip to content

Efficacy and safety analysis of combined application of improved nasal high flow oxygen in painless bronchoscopy

Effect of combined application of improved HFNC on intrapharyngeal pressure in painless bronchoscopy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064284
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory failure

Interventions

A group:high flow nasal cannula
A group:flexible bronchoscopy

Sponsors

Affiliated Hospital of Jiaxing University(The First Hospital of Jiaxing )
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
19 Years to 59 Years

Inclusion criteria

Inclusion criteria: Sixty patients of both sexes, aged 19-59 years, body mass index (BMI) 19.0-29.9 kg/ square meters, ASA grade I-III, were selected for elective painless fiberoptic bronchoscopy.

Exclusion criteria

Exclusion criteria: No fasting or full stomach, laryngeal submucosal hematoma or abscess, gastroesophageal reflux, severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, hematological diseases or coagulation disorders, nasal deformity and luminal tissue hyperplasia, history of habitual epistaxis, maxillary trauma or skull base fracture, allergy to anesthetic drugs, and refusal to participate in this study.

Design outcomes

Primary

MeasureTime frame
Pharyngeal cavity pressure;

Secondary

MeasureTime frame
The cross-sectional area of the antrum;arterial blood gas tests;

Countries

China

Contacts

Public ContactDeng Kang

Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing)

jxmzdk@163.com+86 13736446844

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026